We can't find the internet
Attempting to reconnect
19205.1 PFLS-LS
Discovery & development of novel cancer immunotherapeutics
Résumé
Discovery & development of novel cancer immunotherapeutics
Textes supplémentaires
Abstract
Boosting tumor-directed immune responses by inhibiting tumor evasion mechanisms bears significant therapeutic promise. Although unprecedented clinical success has been achieved by blockade of immune checkpoint pathways, these therapies still have only partial efficacy. Our goal is to develop first-in-class neutralising monoclonal antibodies against a novel immune checkpoint regulator that we have identified, with the aim of strengthening antitumor immunity in cancer patients.
Participants
Walter Reith
Kontaktperson
walter.reith@unige.ch
Université de Genève Walter Reith Rue Michel Servet 1 1211 Genève GE CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2016-08-31
- Date de fin
- 2018-02-28
- Coûts totaux approuvés
- CHF 332545.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%